🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fostering Data Sharing

Search Papers Authors Institutions Grants FAIR About

TheSindex

Fostering Data Sharing

Empowering the data sharing that empowers science — an open, citation-grounded index for datasets.

Product

Search
API
Explore
Rankings

Resources

Methodology
Data Sources
Documentation
Press

Organization

About
Team
Wikidata

© 2026 theSindex. All rights reserved.

Home
Authors
Scott J. Sherman

Scott J. Sherman

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “The Delta-Specific Opioid Glycopeptide BBI-11008: CNS Penetration and Behavioral Analysis in a Preclinical Model of Levodopa-Induced Dyskinesia”.

The Delta-Specific Opioid Glycopeptide BBI-11008: CNS Penetration and Behavioral Analysis in a Preclinical Model of Levodopa-Induced Dyskinesia

International Journal of Molecular Sciences(2020)10.3390/ijms22010020

N/A

0DataRank · unranked

11 citations

Omar S. Mabrouk, Lajos Szabó, Andrew J. Flores, Kate L. Parent, Jean M. Bidlack +6 more

Spectral Signatures of L-DOPA-Induced Dyskinesia Depend on L-DOPA Dose and are Suppressed by Ketamine

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.07.14.202721

N/A

0DataRank · unranked

2 citations

Mitchell J. Bartlett, Scott J. Sherman, Torsten Falk, Stephen L. Cowen, Tony Ye

Spectral signatures of L-DOPA-induced dyskinesia depend on L-DOPA dose and are suppressed by ketamine

Experimental Neurology(2021)10.1016/j.expneurol.2021.113670

N/A

0DataRank · unranked

25 citations

Mitchell J. Bartlett, Scott J. Sherman, Torsten Falk, Stephen L. Cowen, Tony Ye

Antagonism of kappa opioid receptors accelerates the development of L-DOPA-induced dyskinesia in a preclinical model of moderate dopamine depletion

Brain Research(2023)10.1016/j.brainres.2023.148613

N/A

0DataRank · unranked

4 citations

Mitchell J. Bartlett, Blake T. Seaton, Grace Samtani, Morgan R. Sexauer, Nathan C. Weintraub +7 more

Antagonism of kappa opioid receptors accelerates the development of L-DOPA-induced dyskinesia in a preclinical model of moderate dopamine depletion

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.07.31.551112

N/A

0DataRank · unranked

1 citations

Mitchell J. Bartlett, Grace Samtani, Blake T. Seaton, Morgan R. Sexauer, Nathan C. Weintraub +7 more

Differential effects of opioid receptor antagonism on the anti-dyskinetic and anti-parkinsonian effects of sub-anesthetic ketamine treatment in a preclinical model

Neuropharmacology(2024)10.1016/j.neuropharm.2024.110047

N/A

0DataRank · unranked

9 citations

Mitchell J. Bartlett, Chenxi Liu, Alexander Esqueda, Raveena Parmar, Michael L. Heien +3 more

Differential effects of statins on the anti-dyskinetic activity of sub-anesthetic ketamine

Neuroscience Letters(2025)10.1016/j.neulet.2025.138114

N/A

0DataRank · unranked

0 citations

Carolyn J. Stopera, Stephen L. Cowen, Scott J. Sherman, Torsten Falk, Mitchell J. Bartlett